These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28567555)

  • 41. Skin is the most frequently damaged system in recent-onset systemic lupus erythematosus in a tropical region.
    Vilar MJ; Bezerra EL; Sato EI
    Clin Rheumatol; 2005 Aug; 24(4):377-80. PubMed ID: 15599643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO; Corrente JE; Saad-Magalhães C
    Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI).
    Lattanzi B; Consolaro A; Solari N; Ruperto N; Martini A; Ravelli A
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S112-7. PubMed ID: 22588739
    [No Abstract]   [Full Text] [Related]  

  • 44. A comparison of damage accrual across different calendar periods in systemic lupus erythematosus patients.
    Pineau CA; Bernatsky S; Abrahamowicz M; Neville C; Karp I; Clarke AE
    Lupus; 2006; 15(9):590-4. PubMed ID: 17080914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disease evolution in late-onset and early-onset systemic lupus erythematosus.
    Aljohani R; Gladman DD; Su J; Urowitz MB
    Lupus; 2017 Oct; 26(11):1190-1196. PubMed ID: 28420066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study.
    Uhrenholt L; Høstgaard S; Pedersen JF; Christensen R; Dreyer L; Leffers HCB; Taylor PC; Strand V; Jacobsen S; Voss A; Gregersen JW; Kristensen S
    Lupus; 2021 Nov; 30(13):2124-2134. PubMed ID: 34719299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J; Feng R; Carr K; Okawa J; Werth VP
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S; Pereira DA; Costallat LT
    Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus.
    Ma H; Dong J; Wang L; Zhao L; Pan L
    Clin Rheumatol; 2018 Jan; 37(1):101-105. PubMed ID: 28776301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.
    Iaccarino L; Bettio S; Reggia R; Zen M; Frassi M; Andreoli L; Gatto M; Piantoni S; Nalotto L; Franceschini F; Larosa M; Fredi M; Punzi L; Tincani A; Doria A
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):115-123. PubMed ID: 27390293
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
    Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
    Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria.
    Ungprasert P; Sagar V; Crowson CS; Amin S; Makol A; Ernste FC; Osborn TG; Moder KG; Niewold TB; Maradit-Kremers H; Ramsey-Goldman R; Chowdhary VR
    Lupus; 2017 Mar; 26(3):240-247. PubMed ID: 27365370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry.
    Calvo-Alén J; Reveille JD; Rodríguez-Valverde V; McGwin G; Baethge BA; Friedman AW; Alarcón GS
    Lupus; 2003; 12(5):377-85. PubMed ID: 12765301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: analysis of a large monocentric cohort with a long-term follow-up.
    Bortoluzzi A; Furini F; Campanaro F; Govoni M
    Lupus; 2017 May; 26(6):616-622. PubMed ID: 27703051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study.
    Chatham WW; Furie R; Saxena A; Brohawn P; Schwetje E; Abreu G; Tummala R
    Arthritis Rheumatol; 2021 May; 73(5):816-825. PubMed ID: 33225631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Socioeconomic status and organ damage in Mexican systemic lupus erythematosus women.
    Mendoza-Pinto C; Méndez-Martínez S; Soto-Santillán P; Galindo Herrera J; Pérez-Contreras I; Macías-Díaz S; Taboada-Cole A; García-Carrasco M
    Lupus; 2015 Oct; 24(11):1227-32. PubMed ID: 26085596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J; Handwerger B
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance of the 2012 Systemic Lupus International Collaborating Clinics and the 1997 American College of Rheumatology classification criteria for systemic lupus erythematosus in a real-life scenario.
    Amezcua-Guerra LM; Higuera-Ortiz V; Arteaga-García U; Gallegos-Nava S; Hübbe-Tena C
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):437-41. PubMed ID: 25073545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of prospective and retrospective evaluations of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus.
    Bernatsky S; Clarke A; Abrahamowicz M; Neville C; Karp I; Pineau CA
    J Rheumatol; 2005 May; 32(5):820-3. PubMed ID: 15868615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.